In today's episode, Dr. Chi-Ming Chow begins with an introduction and an overview of the new ESC guidelines. He discusses updates on chronic coronary syndromes and diagnostic practices. The focus then shifts to recommendations for intravascular imaging, physiology, and antithrombotic therapy. Dr. Chow also covers the use of GLP-1 drugs, colchicine for residual risk, and advances in atrial fibrillation care. Combined guidelines for vascular diseases and updates on hypertension guidelines are also discussed. Innovations in respiratory health, including a smart mask, are highlighted. The episode addresses the rise in whooping cough cases and explores research on mobile phone use and brain cancer risk. The episode concludes with a summary and sign-off.
(0:00) Introduction and overview of new ESC guidelines
(0:43) Chronic coronary syndromes and updates on diagnostic practices
(1:56) Intravascular imaging, physiology recommendations, and antithrombotic therapy
(3:06) GLP-1 drugs, colchicine for residual risk, and atrial fibrillation care
(4:24) Combined guidelines for vascular diseases
(6:08) Hypertension guidelines update
(7:46) Innovations in respiratory health: Smart mask
(13:37) Public Health Alert: Rise in whooping cough cases
(19:04) Research Insight: Mobile phone use and brain cancer risk
(22:52) Episode conclusion and sign-off